Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
IRCCS Azienda Ospedaliero-Universitaria di Bologna
The aim of this study was to evaluate the clinical results in terms of late skin and subcutaneous toxicity of accelerated hypofractionated forward-planned IMRT in patients with early stage BC. Results were compared with a historical control group (CG) of patients treated with 3D-conformal postoperative RT delivered with conventional fractionation.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
confirmed histologic evidence of pTis-pT3 breast cancer
breast conservative surgery
post menopausal status
clear surgical margin
You may not be if
pT4
positive or close resection margins
3 or more metastatic axillary nodes
nodal irradiation
M1
Clareo Health | Modulated Accelerated RAdiotherapy in Early Breast Cancer
